Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitecharterls.com
Phone+1 (408) 758-4700
Employees
DescriptionLIfe Sciences Venture Firm

Funds

Offices

HQ
2041 Mission College Boulevard
Suite 210
Santa Clara, CA, 95054
USA
Cincinnati, USA
2120 East Galbraith Road
Building A, Room 161
Cincinnati, OH, 45237
USA

People

Managing Partner
Managing Partner
Managing Partner
Partner
Partner and CFO
Managing Director
Managing Director
Investment Professional

Tags

Charter Life Sciences

CHARTER LIFE SCIENCES (“CLS”) is a clinical stage life sciences venture capital investor. CLS makes initial portfolio company investments in life sciences companies that are seeking capital to obtain initial clinical proof-of-efficacy of their products (see Investment Criteria), and they continue to support their successful portfolio companies with follow on investments until they are acquired or go public.

Recent Milestones

Investments

Company Date Round Size Participants
Xlumena 12/2013Series C$25M5
Amaranth Medical 10/2013Series B$20M4
Minimally invasive devices 6/2013Series B$2.5M3
Minimally invasive devices 3/2013Series B$9M2
Xlumena 4/2011Series B$7M5
Great Lakes Pharmaceuticals 8/2010Series B$3.1M4
Corepair 4/2010Series C$4.49M1
CymaBay Therapeutics 11/2009Venture Round$8.6M12
Inviragen 10/2009Series A$15M4
APT Pharmaceuticals 9/2008Series A$32M7
Corepair 2/2008Series B$1.2M1
Bullhorn 6/2006Series C$1.5M2

Videos

Sources

  1. Xlumena Closes $25M in Series C Financing (finsmes.com) [edit]
  2. Insiders, New Investors to Join $25M Series B Round for Amaranth Medical (amaranthmedical.com) [edit]
  3. Minimally Invasive Devices Raises $2.5M In Serise B Funding (finsmes.com) [edit]
  4. Minimally Invasive Devices Completes $9M Series B Financing (finsmes.com) [edit]
  5. Xlumena Closes $7M Series B (pehub.com) [edit]
  6. Great Lakes Pharmaceuticals, Inc.: Series B $3.1M (onbiovc.com) [edit]
  7. SEC filing (sec.gov) [edit]
  8. Metabolex (Metabolex.com) [edit]
  9. Inviragen Completes $15 million Series A Financing (inviragen.com) [edit]
  10. APT Pharmaceuticals Secures $32 Million in Series B Financing (aptbio.com) [edit]
  11. SEC filing (sec.gov) [edit]
  12. Bullhorn Inc. Raises $1.5 Million in Third Round - Boston, MA (nevcfunding.blogspot.com) [edit]
Edit This Page
Last Edited 2/5/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy